Serum Interleukin-6 Level is a Sensitive Parameter of Disease Activity in Rheumatoid Arthritis

Area of Science:

• Immunology
• Rheumatology

Background:

• Interleukin-6 (IL-6) is a key cytokine abundantly expressed in rheumatoid synovium.
• Understanding the clinical utility of serum IL-6 in rheumatoid arthritis (RA) is crucial for disease management.

Purpose of the Study:

• To investigate the clinical usefulness of serum IL-6 levels as a parameter of disease activity in RA.
• To assess the correlation between serum IL-6 levels and established RA disease markers.

Main Methods:

• Serum IL-6 levels were quantified using enzyme-linked immunosorbent assay (ELISA).
• IL-6 levels were compared between RA patients (n=108) and healthy controls (n=10).
• Correlations were analyzed with clinical parameters like Lansbury index, joint score, ESR, and CRP.

Main Results:

• Serum IL-6 levels were significantly higher in RA patients compared to controls.
• IL-6 levels demonstrated significant correlations with conventional RA disease activity indices.
• Serial IL-6 measurements showed potential utility in tracking disease course, with observed benefits in two cases.

Conclusions:

• Serum IL-6 levels represent a potentially sensitive and clinically useful biomarker for assessing disease activity in rheumatoid arthritis.
• IL-6 measurement can aid in monitoring disease progression and evaluating treatment efficacy in RA patients.